Aggressive chemotherapy can trigger inflammation and fuzzy immune signaling that may promote cancer recurrence. Low-dose naltrexone might dampen these maladaptive signals, but only works for patients whose biology matches the data and requires physician supervision.
What if part of your chemotherapy was actually teaching your cancer to come back stronger with inflammation? The runaway inflammation from chemotherapy, or the wrong treatment or too much of a good thing can fuel cancer. When we have too high of a dose of chemotherapy or too much radiation now, we start getting inflammation, stress, and the immunological response gets fuzzy. It's not just what treatment you get, it's the signals that the treatment is sending to your immune system. A repurposed drug called low dose naltrexone may help reduce the the wrong signals, the chronic inflammation, and the damage associated molecular patterns that are involved in cancer. This is only in specific cases where the data matches and is right for the patient in a unique way and in their unique biology. It's not for everyone. You want to be under care of a doctor anytime you're adding or combining to your career.
